its aggregated infectious prion state. These findings are of importance, as they not only shed light on a new pathway for prion export in yeast but also provide a tool to investigate horizontal cell-to-cell transfer of genetic and epigenetic information in yeasts and possibly fungi.
Purification and characterization of yeast EV. We first determined that maximal recovery of EV was achieved from the extracellular medium of yeast cultures grown to early stationary phase in rich yeast extract-peptone-dextrose (YPD) medium (see Text S1 in the supplemental material). We estimated that our purification procedure yielded~2 ϫ 10 13 EV per liter of extracellular medium under these conditions, which corresponds to a final ratio of~200 EV per yeast cell (calculation details can be found in Text S1).
Yeast EV were purified from a [psi Ϫ ] strain and from [PSI ϩ ] S and [PSI ϩ ] W strains, bearing strong and weak prion variants, respectively, by using the optimized protocol described in Text S1 in the supplemental material (see also Fig . S1A in the supplemental material). EV preparations from all three strains had similar electrophoretic protein profiles when examined by SDS-PAGE (see Fig. S1B ) and contained, as expected, membrane vesicles visible by electron microscopy (see Fig. S1C ). The morphology of these vesicles was consistent from one preparation to another, most of them being round, ovoid, or cup-shaped (see Fig. S1C ). The vesicle diameters spanned between~20 and~300 nm, with most EV in the~50-to-100-nm range (see Fig. S1D (Fig. 1A) . Slight variations in the levels of Sup35p detected in EV were observed in biological replicates, e.g., independent preparations (data not shown). EV isolated from [psi ؊ ] cells contained in a consistent manner less Sup35p than those isolated from [PSI ϩ ] cells (see Fig. S2 in the supplemental material). Cytosolic molecular chaperones of the Hsp70 (Ssa1p), Hsp110 (Sse1p), and Hsp40 (Sis1p) families were detected within EV preparations (Fig. 1A) . lysates and EV were then prepared and analyzed by SDS-PAGE and Western blotting using antibodies against the indicated proteins. (B) EV were fixed with 2% paraformaldehyde, adsorbed onto electron microscopy grids, and permeabilized with 0.02% Triton X-100 for 10 min. Immunogold labeling of Sup35p was then performed using primary polyclonal anti-Sup35p antibody and secondary anti-rabbit 10-nm-gold-conjugated antibodies. Electron microscopy grids were fixed with 1% glutaraldehyde for 5 min at room temperature and visualized by negative-stain electron microscopy. Bars, 100 nm. Arrowheads point to gold-labeled Sup35p-positive vesicles. (C) Purified EV were incubated with or without 2% Triton X-100 for 30 min on ice, before the addition of 0.01 mg ml Ϫ1 proteinase K. Reaction mixtures were further incubated for 15 min on ice and stopped with the addition of 2 mM phenylmethylsulfonyl fluoride. An untreated control reaction mixture (without Triton X-100 and without proteinase K) was run in parallel under identical conditions. Reaction products were then analyzed by SDS-PAGE and Western blotting using the indicated antibodies. (D) Purified EV produced by [PSI ϩ ] S cells were incubated with or without 1% Triton X-100 for 30 min at 4°C. The mixture was adjusted to 60% sucrose in 20 mM HEPES-OH (pH 7.5) and deposited in the bottom of an ultracentrifuge tube. Equal volumes of 40% and 20% (wt/wt) sucrose solutions in 20 mM HEPES-OH (pH 7.5) were successively layered on top of the EV suspensions. Following centrifugation for 17 h at 150,000 ϫ g and at 4°C, 10 fractions were collected from the top of the gradients and analyzed by SDS-PAGE and Western blotting using the indicated antibodies (T stands for total and represents the input material).
These also contained the clathrin heavy-chain protein Chc1p and the endoplasmic reticulum Hsp70 family member Kar2p, but they did not contain detectable amounts of proteasomes (20S) or the Ydj1p and Hsp104 molecular chaperones (Fig. 1A) . With the notable exception of Sup35p, most of the proteins we found associated with EV were also identified in a proteomic study of yeast EV proteins (17) . The reasons why Sup35p was not identified in that study are unclear, but this may have been due to the different yeast genetic backgrounds used and/or to the different growth conditions, particularly the use of Sabouraud dextrose broth instead of YPD agar (YPDA) medium and a growth temperature of 25°C instead of 30°C (17) . All of these parameters may have consequences on protein expression levels and ultimately on the composition of the EV proteome. Furthermore, the yeast strains used by Oliveira et al. were likely in the [psi ؊ ] state and thus contained less Sup35p than our [PSI ϩ ] cells (for instance, see Fig. S2 ) (17) . Alternatively, the identification of Sup35p may have not withstood the stringent filtering criteria that were applied at each step of the mass spectrometry analysis (17) . Immunogold labeling and electron microscopy revealed the presence of Sup35p inside Triton X-100-permeabilized EV (Fig. 1B ). EV were not stained by the secondary gold-conjugated antibody in the absence of primary anti-Sup35p antibodies, confirming that the immunogold labeling procedure was specific for Sup35p (see Fig. S3 in the supplemental material). Most (~75%) Sup35p-positive vesicles had a diameter of~30 to 100 nm, suggesting that they correspond to exosomes (see Fig. S4 in the supplemental material). We demonstrated the EV intraluminal localization of Sup35p and Hsp70 by subjecting EV to proteinase K treatment. Sup35p and Hsp70 resisted cleavage in intact EV but not in the presence of Triton X-100 (Fig. 1C ). Sup35p and Hsp70 colocalized with EV proteins in sucrose gradients, and their flotation in the gradients was altered upon solubilization of EV with Triton X-100 (Fig. 1D) . Furthermore, Sup35p and Hsp70 remained associated with EV in sucrose gradient separations under high ionic strength (see Fig. S5 Fig. 2A, right panel) . As reported previously (20) , the size distribution of SDS-resistant Sup35p polymers visualized by SDD-AGE changed upon entry of cells into stationary phase ( Fig. 2A ; compare log-phase and earlystationary-phase [PSI ϩ ] samples). Sup35p SDS-resistant polymers appeared slightly larger in [PSI ϩ ] W than in [PSI ϩ ] S cell lysates, regardless of the growth phase, as reported previously (21, 22) . The apparent molecular weight of Sup35p polymers within [PSI ϩ ] EV appeared much higher than that of Sup35p polymers in lysates of the early-stationary-phase cells from which they originated ( Fig. 2A ; compare early-stationary-phase and EV [PSI ϩ ] samples). The size distribution of Sup35p polymers within [PSI ϩ ] EV was, however, comparable to that of Sup35p polymers found within lysates prepared from exponentially growing cells ( Fig. 2A ; compare log-phase and EV [PSI ϩ ] samples). These observations suggest that most Sup35p prion particles are packaged during the exponential phase of growth before being progressively released in the extracellular medium, possibly in relation to glucose consumption (23) . Alternatively, conformational rearrangements of Sup35p prion particles within EV could also account for the observed size differences between intracellular and intravesicular high-molecular-weight species. Regardless, our data suggest that both soluble and aggregated Sup35p molecular species are released from cells via export in EV. These results were confirmed by the finding that green fluorescent protein (GFP)-tagged Sup35p (see Text S1 in the supplemental material) displayed a punctate pattern (characteristic of aggregates) and a diffuse dim pattern (characteristic of soluble entities) in EV purified from [PSI ϩ ] and [psi Ϫ ] cells, respectively, as visualized by fluorescence microscopy (see Fig. S6 in the supplemental material) .
Remarkably, Sup35p prion particles within EV prepared from [PSI ϩ ] cells were able to confer the prion state when transformed into [psi Ϫ ] cells (see Text S1 in the supplemental material for details) (Fig. 2B) Fig. S7 in the supplemental material).
To our knowledge, our study provides the first evidence for EV-mediated export of a prion in yeast (Fig. 1) . Of particular importance is the finding that prion particles within EV fully retain their infectious and strain-specific prion state (Fig. 2) , meaning they could in principle mediate horizontal cell-to-cell propagation of yeast prions.
Packaging of soluble and aggregated Sup35p in EV. We demonstrated using immunogold labeling and electron microscopy, proteolysis resistance assays, and flotation assays that both soluble and aggregated Sup35p are within EV, not at their surface (Fig. 1B , C, and D; see also Fig. S3 and S5 in the supplemental material). Sup35p was mostly found inside vesicles with a diameter of~30 to 100 nm, e.g., exosomes ( Fig. 1B ; see also Fig. S3 in the supplemental material). A small proportion (25%) of Sup35p was detected in larger vesicles (~100 to 180 nm in diameter) that may, or may not, correspond to ectosomes directly originating from plasma membrane budding ( Fig. 1B ; see also Fig. S3) (9, 11) . Given the limited differences in size and density, we were not able to obtain homogeneous preparations of each type of vesicle. In addition, specific differences in cargo content that may be helpful in distinguishing exosomes from ectosomes have yet to be established in yeast. Therefore, other strategies will be required to ascertain the exosomal or ectosomal origin of Sup35p-containing EV.
Important questions that also need to be addressed in future studies include how aggregated Sup35p prion particles are addressed to vesicles and which cellular factors (e.g., molecular chaperones) and/or cellular structures (e.g., cytoskeleton) assist in this process. Sup35p is a cytosolic protein that does not, to the extent of our knowledge, enter the secretory pathway. Surprisingly though, both soluble and aggregated Sup35p were found in EV ( Fig. 2 ; see also Fig. S6 in the supplemental material) . A plausible explanation for this localization would be either that Sup35p is secreted to the extracellular space or that it is directed toward autophagic destruction, or both (9, 24) . The stochastic trapping of Sup35p into prevesicular structures is unlikely to account for Sup35p encapsulation within EV. Indeed, only a subset of cytosolic molecular chaperones was found within EV (Fig. 1A) , suggesting the existence of cargo selectivity mechanisms.
The sizes of SDS-resistant Sup35p assemblies within [PSI ϩ ] EV and cell lysates from log-phase [PSI ϩ ] cells were alike ( Fig. 2A) . These Sup35p assemblies were, however, much larger than those found in lysates prepared from the early-stationary-phase [PSI ϩ ] cells harvested at the end of culturing ( Fig. 2A) . This observation suggests that the packaging of Sup35p aggregates within vesicles occurs in actively dividing cells. Entry into stationary phase upon glucose exhaustion may significantly slow vesicle formation and trafficking, but it may in turn trigger the release of preformed vesicles in the extracellular space (23) . In line with this notion, we were not able to isolate significant amounts of EV from cell cultures in the log phase of growth (data not shown). Although less likely, we cannot rule out the alternate possibility that Sup35p aggregates are remodeled within EV or that bigger aggregates are preferentially targeted for EV-mediated release. Regardless, Sup35p prion particles within EV fully retained their infectious potential (Fig. 2B) and their ability to transmit their strain-specific conformations (Fig. 2C) , indicating that they are unlikely to represent dead-end aggregation products.
In light of our data, EV-mediated export of prions does not seem to constitute a prion clearance mechanism, as [PSI ϩ ] is faithfully maintained during growth. However, packaging and export of prions (and possibly that of other aggregated or misfolded protein species) in EV may constitute a way to reduce the burden on the cellular protein quality-control machineries and improve cell fitness.
EV as vehicles for horizontal cell-to-cell transfer of yeast prions? Our data show that EV constitute a natural source of infectious Sup35p particles, raising the intriguing possibility that EV could be new mediators of prion spreading among yeasts. Our attempts to induce prion formation by incubating [psi Ϫ ] cells with purified EV or with EV-containing conditioned medium from [PSI ϩ ] cells were, as per now, inconclusive but did not yet rule out the existence of such a cell-to-cell transfer of yeast prions. Uptake of exogenous vesicles by yeasts requires overcoming the cell wall physical barrier, which appears to be an unsurmountable obstacle for such big particles, at least under standard laboratory growth conditions (11) . The efficient internalization of EV trapped between the plasma membrane and the cell wall has been demonstrated to occur when the growth medium is replenished with glucose (23) . In contrast, neither the mechanism by which EV are able to cross the yeast cell wall to be released in the medium nor that of EV capture and uptake from the medium are known (11) . These processes may require particular and yet-to-be-identified growth conditions and/or environmental cues that may, for example, induce changes in the mechanical properties of the cell wall (25) . Intercellular transfer of EV may also require direct cell-tocell contacts, such as those occurring in colonies or biofilms. We can envision conditions in the wild where multiple individuals within a microbial community-yeast and/or other microbesshare a cell wall or analogous polysaccharide extracellular matrix that allows the exchange of information via the secretion and uptake of EV.
Conclusions. EV are under intense scrutiny from the biomedical research community due to the key roles they may play in horizontal cell-to-cell communication and in the transfer of pathogenic and virulence factors, to their potential use as diagnostic markers in many cancers or neurodegenerative diseases, and to their use as vehicles for drug delivery. The findings we report here establish yeast prions as powerful tractable biological models to specifically investigate the molecular mechanisms of vesiclemediated export of infectious protein assemblies and as a new tool to investigate the EV-mediated horizontal transfer of information in yeasts and fungi.
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